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 It is shown here that preterm infants, of all gestational ages, with a poor short-term health outcome, are unable to 
significantly alter their heart-rate variability (HRV) in response to low blood pressure events. This differs from 
healthy preterms, where a clear change in HRV in response to hypotension is demonstrated. 
 The predictive power of HRV features for short-term health prediction in preterm infants improves when observed 
during episodes of hypotension.  
 An objective decision support tool for clinical prediction of short-term outcome in preterms with hypotension was 
constructed based on multimodal HRV and blood pressure data. 
 The best performing decision-support system based on the HRV features extracted during hypotensive episodes, 
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Background and Objective: 
Efficient management of low blood pressure (BP) in preterm neonates remains challenging with considerable variability in 
clinical practice. There is currently no clear consensus on what constitutes a limit for low BP that is a risk to the preterm 
brain. It is argued that a personalised approach rather than a population based threshold is more appropriate. This work aims 
to assist healthcare professionals in assessing preterm wellbeing during episodes of low BP in order to decide when and 
whether hypotension treatment should be initiated. In particular, the study investigates the relationship between heart rate 
variability (HRV) and BP in preterm infants and its relevance to a short-term health outcome. 
Methods: 
The study is performed on a large clinically collected dataset of 831 hours from 23 preterm infants of less than 32 weeks 
gestational age. The statistical predictive power of common HRV features is first assessed with respect to the outcome. A 
decision support system, based on boosted decision trees (XGboost), was developed to continuously estimate the probability 
of neonatal morbidity based on the feature vector of HRV characteristics and the mean arterial blood pressure. 
Results: 
It is shown that the predictive power of the extracted features improves when observed during episodes of hypotension. A 
single best HRV feature achieves an AUC of 0.87. Combining multiple HRV features extracted during hypotensive episodes 
with the classifier achieves an AUC of 0.97, using a leave-one-patient-out performance assessment. Finally it is shown that 
good performance can even be achieved using continuous HRV recordings, rather than only focusing on hypotensive events – 
this had the benefit of not requiring invasive BP monitoring. 
Conclusions: 
The work presents a promising step towards the use of multimodal data in providing objective decision support for the 
prediction of short-term outcome in preterm infants with hypotensive episodes. 
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1. INTRODUCTION 
Every year, more than one in ten babies are born preterm and this number is rising [1]. Premature babies are at a higher 
risk of complications, which may lead to both short-term and long-term adverse health outcomes, including neuromotor, 
cognitive, hearing, and visual problems. Low blood pressure (BP) or hypotension is a recognised problem in preterm infants 
particularly during the first 72 hours of life. This may result in inadequate blood flow to the brain and other vital organs. The 
definition of hypotension is still uncertain and the decision to intervene in the preterm infant with low BP is still unresolved; 
this has resulted in considerable variability in the practice of hypotension management [2–4]. When the level of mean arterial 
pressure (MAP) falls below the gestational age (GA) in weeks, an intervention in the form of volume expansion is commonly 
initiated. This approach, however, lacks supporting evidence. At the same time, hypotension treatment has been associated 
with adverse outcomes [5,6], including brain injury [7]. For babies with no clinical or biochemical signs of shock, no 
intervention may be the most appropriate management [8]. The “Hypotension in Preterm Infants” trial was aimed at 
determining whether a standard approach to the management of hypotension with volume expanders and dopamine, versus a 
more observational approach with placebo, would result in improved short-term and long-term outcomes for preterm infants 
[8]. 
The ability to objectively assess preterm wellbeing during episodes of low BP may improve the efficacy of hypotension 
management. ECG is routinely recorded in preterm infants from which the time variation between successive heartbeats 
(heart rate variability, HRV) can be estimated. HRV provides a non-invasive assessment of both the sympathetic and 
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parasympathetic control of the heart rate [9]. HRV analysis is uniquely suitable to explore the influence of the immature 
autonomic system on cardio-respiratory control in preterm neonates.  
ECG has been used extensively for assessing aspects of newborn health. Promising results have been obtained for 
automated computer-based outcome prediction in full term neonates using a combination of multimodal features including 
HRV and EEG [10]. In term neonates, a significant association between HRV, severity of hypoxic ischemic brain injury and 
long-term neurodevelopmental outcome at two years of age was reported for 61 full-term neonates [11].  
For the preterm population, different physiological modalities have also shown promise in predicting neurodevelopmental 
outcome [12,13]. A quantitative analysis of EEG, heart rate, peripheral oxygen saturation and other clinical features from 
forty three preterm infants was conducted. Logistic regression of all combined measures showed the potential for the 
prediction of both mortality and 2-year outcome [12]. 
HRV features together with the quantification of general physical movements were also found to be useful for 2-year 
outcome prediction in preterms [14]. The high frequency component of preterm HRV was shown to be a good biomarker of 
necrotizing enterocolitis, an acute neonatal inflammatory disease which may lead to death [15]. Time-domain HRV 
measurements have shown significant differences between septic and non-septic newborns [16]. Lower HRV was observed in 
children with low birth weight, including preterm babies [17]. HRV has been assessed as a predictor for successful removal 
of mechanical ventilation [18]; it was demonstrated that babies who failed their first extubation had decreased HRV. A 
correlation between low frequency oscillation of HRV and BP for preterm neonates has also been reported [19]. Another 
study on 92 preterm neonates revealed a significant association between neonatal HRV and respiratory distress syndrome, 
and proposed the use of HRV as an indicator of morbidity and mortality in preterm infants [20]. HRV was also shown to be 
effective for the monitoring of preterm neonates in the NICU. The heart rate observation monitor (HeRO) [21] which allows 
for the detection of sepsis in preterm infants, based on three (SDNN, sample asymmetry and sample entropy) HRV 
characteristics is now used in many NICUs. Results of a large randomised clinical trial have reported a reduction in mortality 
(from 10.2% to 8.1%) when providing a sepsis score to the medical staff in real time [22].   
While several studies have identified an association between HRV and neonatal health outcomes in term and preterm 
infants, there is still a lack of understanding about this relationship in the context of low BP episodes in preterm infants. This 
study aims to investigate the relationship between HRV and BP and short-term health outcome in preterm infants with a GA 
less than 32 weeks. In particular, the usefulness of various HRV features for the estimation of short-term health outcome is 
assessed and the predictive power of the combination of HRV features in a classifier during the episodes of low BP is 
studied. 
2. MATERIALS AND METHODS 
2.1. Dataset 
The data used in this work is a subsample of a larger dataset reported by Lloyd et al [12]. Out of a total of 43 preterm 
neonates, 23 had continuous blood pressure monitoring and were used in this study. The clinical dataset was recorded at the 
neonatal intensive care unit of Cork University Maternity Hospital, Ireland. The study had full ethical approval from the 
Clinical Research Ethics Committee of the Cork Teaching Hospitals. The dataset includes continuous synchronously 
recorded ECG and BP signals with a total duration of 831 hours (median = 38 hours, IQR: 24 to 48 hours). Clinical 
characteristics of the dataset are provided in Table 1. The temporal location of each recording with respect to the time of birth 
for each infant is shown in Figure 1. 
 
Fig. 1. Schematic representation of the duration and temporal location of recordings.  


















Table 1. Clinical information for preterms in the dataset. CCS, clinical course score; ROP, retinopathy of prematurity; NEC, necrotizing 
enterocolitis; BPD, bronchopulmonary dysplasia, CNS, central nervous system complications (grade III/IV intraventricular haemorrhage or 












Sepsis CNS NEC BPD ROP CCS 
1 30 1540 F 8 0 0 0 0 0 0 
2 28 980 F 10 1 0 0 0 0 1 
3 30 1450 M 5 1 1 0 0 0 1 
4 29 1230 M 9 0 0 0 0 0 0 
5 26 840 M 8 0 0 0 0 0 0 
6 25 640 F 6 1 - - - 0 1 
7 31 960 F 9 0 0 0 0 0 0 
8 28 980 F 8 0 0 0 0 0 0 
9 28 650 F 7 0 0 0 0 0 0 
10 28 530 F 6 0 0 0 0 0 0 
11 26 860 M 8 1 0 0 0 0 1 
12 26 980 M 8 1 0 0 0 0 1 
13 24 740 F 9 0 0 1 0 0 1 
14 24 670 M 6 0 0 1 0 0 1 
15 28 1040 F 9 0 0 0 0 0 0 
16 23 540 F 7 1 0 1 1 0 1 
17 26 660 F 3 1 0 1 1 0 1 
18 28 1330 F 4 0 0 0 0 0 0 
19 30 730 M 10 0 0 0 0 0 0 
20 23 580 F 6 0 0 0 1 0 1 
21 28 680 M 8 1 0 0 1 0 1 
22 28 1130 F 9 0 0 0 0 0 0 

































One-channel ECG was recorded on a Natus NicOne video EEG machine (CareFusion Co., San Diego, USA). ECG data 
were sampled at 256 Hz (20 subjects) or 1024 Hz (3 subjects). Continuous invasive arterial BP monitoring was 
simultaneously recorded via an umbilical arterial catheter using the Philips Intellivue MP70 machine (with direct output to 
the Natus NicOne), which provides BP data sampled at 1 Hz. All infants were nursed supine. The positioning of the tip of the 
umbilical catheter in the descending aorta was confirmed by chest radiograph. An example of a data segment is presented in 
Figure 2. 
 
Fig. 2. One minute of raw ECG and ten minutes of mean arterial pressure (MAP) recordings (GA=26 weeks). 
 
The well-being of the newborn infant in the NICU can be quantified by a number of measures. Illness scores are widely 
used for neonates as they allow for standardised comparisons. Figure 3 schematically represents the timing of the various 
illness scores including Apgar score, clinical risk index for babies (CRIB II) and clinical course score (CCS). All scores 
summarise various criteria of the well-being of the neonate on the different stages. This study concentrates on the usage of 

















Fig. 3. The timing of illness scores assigned to an infant during the course in the neonatal intensive care unit (NICU). In-patient risks 
include major neonatal complications: IVH (intraventricular haemorrhage), cystic periventricular leukomalacia, necrotizing enterocolitis, 
infection (sepsis), retinopathy of prematurity (ROP). The diagram is adapted from Lloyd et al. [12]. 
 
The CCS is a binary score assigned independently to every infant by two consultant neonatologists at discharge [12]. 
When grades differed between reviewers, a consensus was reached by discussion. The CCS was based on information from 
the discharge summary and medical notes summarising the presence or absence of at least one out of five major neonatal 
complications: 1) grade III/IV intraventricular haemorrhage or cystic periventricular leukomalacia (CNS, central nervous 
system complications); 2) bronchopulmonary dysplasia defined by oxygen dependency at 36 weeks postmenstrual age 
(BPD); 3) necrotizing enterocolitis Bells stage 2b or greater (NEC); 4) infection defined as positive blood culture with 
abnormal inflammatory markers (sepsis); and 5) retinopathy of prematurity of stage 2 or greater (ROP). In the cohort used in 
this study 12 out of 23 neonates had a good short-term outcome.  
While both EEG and ECG are used for assessing newborn health [10], this study incorporates only HRV recording. HRV 
characterizes physiological stability within the first 72 hours of life and therefore is considered as a more suitable method for 
the prediction of short-term health status associated with the development of different morbidities that constitute the CCS. 
A recent survey has confirmed that the most common criterion used by neonatologists to direct intervention for 
hypotension management is when the level of mean arterial pressure (MAP) falls below GA [23]. In this study, we aim to 
investigate the effect of hypotension on preterm wellbeing. The term „hypotension‟ in this work does not confer a clinical 
diagnosis, but simply refers to episodes when the BP (MAP) falls below some specified age-related (GA) threshold. Three 
thresholds were considered in this work: MAP ≤ GA, MAP ≤ GA + 2 mmHg and MAP ≤ GA + 4 mmHg. Each threshold 
results in a subset of preterm neonates who had at least one hypotensive episode of at least 5 min duration. For example, only 
15 preterms (8 healthy) out of 23 will satisfy the threshold of MAP ≤ GA – that is; only 15 subjects will have at least one 
episode of hypotension as defined by the threshold. Similarly, allowing the threshold to be larger, more preterms will be 
included – for MAP ≤ GA+2 mmHg the resultant dataset contains 19 preterms (10 healthy) and for MAP ≤ GA+4 mmHg the 
resultant dataset contains all 23 subjects (12 healthy). The episodes under the chosen threshold were marked as “hypotensive” 
episodes in each recording. The influence of the threshold on the definition of hypotensive episodes will be studied with 
respect to the ability of HRV features to predict outcome.  
2.2. Signal Preprocessing and Feature Extraction  
Segments which were highly corrupted by artefacts were excluded from the study. 
2.2.1. MAP  
The diastolic (DP) and systolic (SP) pressures were recorded every second and used to calculate the MAP as     
                 The segments with MAP < 10 mmHg were excluded to remove artefacts due to brief disconnection of 
the pressure transducer or movements. The MAP was then segmented into 1-hour windows. Values beyond ±3 SD were 
marked and then discarded. This allowed for the removal of sharp and non-physiological changes in MAP and this was 
confirmed by neonatologist (ED). The values of MAP can also be affected by interventions such an infusions given through 
the umbilical line. The ten minutes of the MAP signal before and after any marked interventions were also eliminated. 
2.2.2. ECG features 
The ECG signal was segmented into non-overlapping 5-minute epochs. The R-peaks were identified using the Pan-
Tompkins method [24]. The normal range of the heart rate changes with maturation. In order to account for this difference 
















frequencies instead of the originally proposed 5-15 Hz. Increasing the low-pass cut-off frequency to 30 Hz emphasises the R-
peaks to better distinguish between the R-peak and the P-wave. No manual inspection of the detected R-peaks was 
conducted. Abnormal values of time intervals between R-peaks (RR intervals) caused by artefacts were corrected by the 
moving average filter or discarded if the epoch was too corrupted. The corrected RR intervals, NN intervals, were used to 
estimate the instantaneous heart rate signal. 
The behaviour of HR was quantified using time-domain and frequency-domain analysis. Thirteen HRV characteristics 
were extracted from the RR intervals (Table 2).  
 
Table 2. Frequency- and time-domain features extracted from ECG, and BP. 
Domain HR features 
Time MeanRR, SDNN, skewness, kurtosis, TINN, RMSSD, 
SDNN/RMSSD, ApEn, Allan Factor 
Frequency Power in VLF (0.008 – 0.04 Hz), LF (0.04 – 0.2 Hz) and 
HF (0.2 - 1 Hz) bands, ratio LF/HF 
 BP features 
Time MAP, MAP–GA, MAP/GA 
 
The time domain features were derived using simple statistics of RR interval distribution and include the mean of the RR 
interval (MeanRR), the standard deviation of NN interval (SDNN), which reflects all the periodic components responsible for 
the variability in given epoch; skewness and kurtosis of NN distribution; triangular interpolation of the NN histogram 
(TINN), defined as the width of the baseline of an imaginary triangle that best approximates the histogram of the NN signal 
[25]. Other features include the temporal information, such as root mean square of successive RR intervals (RMSSD) and the 
ratio between SDNN and RMSSD. 
Nonlinear methods of HRV analysis can provide additional information about the autonomic control of heart rate. 
Nonlinear HRV features include approximate entropy (ApEn) to quantify regularity and complexity of stationary signal [26] 
and the Allan Factor (AF), a scale-dependent measure which quantifies the variability of successive counts [27]. AF is 
defined as the ratio of the variance of successive counts for a specific counting number t divided by twice the mean of events 
in the counting time. In this study, AF is calculated for every 5-minute epoch of NN intervals, with a time scale t = 1 minute.  
Frequency domain features were obtained from the uniformly resampled NN intervals, at 256 Hz. HRV was then 
quantified by power in the various bands: very low frequency (0.008 – 0.04 Hz) band (VLF); low frequency (0.04 – 0.2 Hz) 
band (LF), high frequency (0.2 - 1 Hz) band (HF) as well as the ratio between the LF and HF power (LF/HF). The power in 
these three bands and the ratio LF/HF is a reflection of both sympathetic and parasympathetic response. For some HRV 
features (VLF, LF, HF, LF/HF, SDNN, TINN, skewness, kurtosis and ApEn) the NN intervals were normalized with respect 
to the average (over epoch) NN interval [28]. These features have been previously used for various purposes to quantify the 
HRV in term and preterm infants [10, 27]. To the best of our knowledge, these features have not been previously researched 
with respect to BP. For this reason, a diverse set of HRV features was retained to examine which features are useful for the 
task.  
 
2.3. Statistical Modelling 
2.3.1. Predictive power of HRV characteristics 
The area under the receiver operating characteristic curve (AUC) is used to quantify the discriminative (predictive) power 
of each HRV feature with respect to the health status of the preterm, which is represented by CCS. The receiver operating 
curve is constructed with a set of sensitivity and specificity values which are obtained by thresholding each feature. The AUC 
is directly connected to the Mann-Whitney U-statistic (AUC is the U-statistic normalised by the product of positive and 
negative sample sizes). U-statistic is a robust non-parametric alternative to the student‟s t-test to assess the difference 
between two distributions [30].  
2.3.2. Boosted decision trees 
In order to check the discriminative capability of a combination of features, a boosted decision trees classifier was used. 
Boosting is a method for the creation of an accurate and strong classifier from a set of weak classifiers [31]. Gradient boosted 
decision trees is a machine learning technique for both regression and classification problems, which produces a prediction 
model in the form of an ensemble of decision trees which are built in a stage-wise fashion by optimizing an arbitrary 
differentiable loss function [32]. The extreme gradient boosting classifier, XGBoost [33] is a well-known implementation of 
regularised boosted decision trees which is available as open source software. The package has been widely recognized in a 
number of machine learning and data mining challenges, (e.g. in Kaggle competitions), where state-of-the-art results on a 
















We have also investigated the interaction of various HRV features [34]. The interaction between two features is defined as 
a path of length 2 within a tree and is calculated by summing the node gains (Eq. A.5) along the corresponding decision path. 
The process is repeated for every pair of features in each decision tree from the tree ensemble. 
The XGBoost [33] package implements two additional techniques for regularization. The first one is shrinkage, which 
scales newly added weights by a factor, η, after each step of tree boosting. This reduces the influence of each individual tree 
and leaves space for future trees to improve the model. The second is the column (feature) subsampling which is used in 
Random Forests [35], where only a random subset of features is considered while constructing a given tree. The most 
important user-tuneable parameters of an XGBoost classifier are thus the depth of the tree, the feature and data subsampling 
ratios, as well as the number of iterations which is a function of the learning rate. 
2.4. Model selection and performance assessment 
Whereas using the statistical methods the predictive power of each feature is computed on the whole dataset, the 
application of machine learning tools requires a clearly defined performance assessment routine – the split of data used for 
model training and for model testing. The leave-one-patient-out (LOO) subject independent performance assessment is used 
in this work to estimate the generalisation error. All but one subject‟s data are used for training and the remaining subject‟s 
data are used for testing. The procedure is repeated until each patient has been a test subject (Figure 4). The LOO method is 
known to be an almost unbiased estimation of the true generalization error [36], i.e. the error reported with this routine is the 
most correct estimation of the error this system would get by testing on a separate unseen dataset of infinite size once it is 
trained on all available data. 
 
 
Fig. 4. A diagram of LOO subject independent performance assessment and 5 times 2-fold CV model selection routines. 
 
The XGBoost classifier has a number of user-tuneable parameters (hyperparameters). In order to balance between 
underfitting and overfitting, an optimisation of hyperparameters is performed using an exhaustive search through manually 
specified range for each hyperparameter. The routine used to tune the parameters is called model selection. The 
hyperparameters were tuned using the stratified 5 times 2-fold cross validation (CV) [37], performed on the training data, 
once the split of the whole data to train and test has been executed (Figure 4). The CV folds were designed in a way that 
preserves the subject integrity – that is no subject data appear in two different folds. This allows for the model selection 
routine to have the optimization criteria that matches the one of the LOO performance assessment routine. In other words, the 
model selection routine searches for hyperparameters that maximise the performance on unseen patients in the internal CV, 
and these parameters are then used to train the model which is assessed on a single unseen patient in the external LOO loop. 
The performance assessment routine is thus independent of the model selection routine, and the testing patient is not seen or 
used for training the classifier or tuning of other system parameters at any time. The best performing parameter set is saved 
for each LOO iteration. The analysis of stability of the classifier is then performed by examining the most frequent set of 
hyperparameters used to train the classifier.  
The performance of the classifier was similarly measured by the AUC metric. When an epoch of the physiological data (a 
vector of HRV features) is fed into the XGB classifier, the probability of abnormal outcome is returned for this epoch. These 
probabilities are then compared to the ground truth (outcome scores) and the AUC is computed across all epochs. The ground 
















patient is also calculated, resulting in a single probabilistic value per subject which represents the level of the algorithmic 
support for the abnormal outcome decision. The subject level AUC is then obtained by contrasting the averaged probabilities 
with the outcome labels. The two ways to compute the AUC are designed to assess the instantaneous accuracy of the 
classifier (epoch-based AUC) as well as the accuracy when the whole recording is available (subject-based AUC).  
3. RESULTS 
The statistical predictive power of each HRV feature is presented in Table 3. The “healthy” and “unhealthy” outcome 
labels correspond to neonates with normal and poor CCS respectively. The AUC of each HRV feature is computed on the 
subsection of the data for each of the pre-defined thresholds (Set 1, Set 2, Set 3) as discussed in Section 2.1. For a given 
threshold, the AUC is computed on all available epochs from the qualifying babies (All epochs) and on epochs that belong to 
episodes of hypotension (Hypotensive events) as defined by the threshold; the statistically significant differences (p-
value<0.001) are indicated in bold. Table 3 compares the predictive power of each particular feature when MAP is taken into 
consideration across different definitions of hypotension.  
Examining HRV during the episodes of low BP improves the predictive power of every relevant HRV feature in all three 
Sets. For example, in Set 3 RMSSD improved from AUC of 0.76 to 0.87, in Set 2 from AUC of 0.77 to 0.93 and in Set 1 
from AUC of 0.77 to 0.97. The improvement increases with tighter definitions of Hypotensive events through the GA-based 
threshold. 
Figure 5 shows the probability density functions of the best performing RMSSD feature for the whole dataset, the subset 
with normal BP and the subset of Hypotensive events (MAP ≤ GA+4) for the cohort of preterms with both healthy and 
unhealthy outcomes. These PDFs are demonstrated for 1) babies of all ages (All GA, 23 subjects), 2) babies with GA>28 
subset (6 subjects, 1 poor outcome), and 3) babies with GA≤28 subset (17 subjects, 10 poor outcomes). All distributions for 
hypotensive events demonstrate a shift in the distributions towards the right in preterm infants with a good outcome.  
 
Table 3. Predictive power of the HRV features measured using AUC. „All epochs‟ represents complete recordings. „Hypotensive events‟ 
represents only epochs under the specific MAP threshold (GA, GA+2 or GA+4) for the same set of babies. The comparison between the 
AUC values obtained for „All epochs‟ and „Hypotensive events‟ was performed using the non-parametric DeLong method for AUC 
comparison [38]. The significantly different AUC (p-value<0.001) are indicated in bold. “Healthy” and “unhealthy” labels correspond to 
neonates with normal and poor CCS outcomes. 
HRV features 
Set 1  
MAP ≤ GA, 15 subj 
(8 healthy) 
Set 2  
MAP ≤ GA+2, 19 subj 
(10 healthy) 
Set 3  

















VLF 0.66  0.86  0.70 0.77  0.67 0.70 
LF 0.74 0.89 0.78 0.81 0.76 0.78 
HF 0.65 0.90 0.68 0.84 0.64 0.76 
LF/HF 0.69 0.73 0.72 0.68 0.73 0.69 
MeanRR 0.82 0.84 0.78 0.83 0.82 0.85 
SDNN 0.65 0.85 0.68 0.80 0.65 0.73 
TINN 0.7 0.89 0.73 0.83 0.70 0.77 
Skewness 0.52 0.60 0.56 0.51 0.58 0.52 
Kurtosis 0.57 0.58 0.57 0.61 0.56 0.61 
ApEn 0.70 0.92 0.69 0.85 0.67 0.78 
RMSSD 0.77 0.97 0.77 0.93 0.76 0.87 
SDNN/RMSSD 0.61 0.71 0.66 0.68 0.64 0.65 


















Fig. 5. PDF for the RMSSD feature. Original subset (a) contains RMSSD feature values from the complete recordings. Normal (b) and 
hypotensive (c) subsets represent RMSSD feature extracted during episodes of normal BP (MAP > GA+4) and during hypotensive events 
(MAP ≤ GA+4). PDFs are given for all 23 subjects (All GA), babies with GA>28 (6 subjects) and babies with GA≤28 (17 subjects). 
The separation between distributions increases when considering only hypotensive episodes, Figure 5 (c). Comparing the 
Figure 5 (b, all GA) and Figure 5 (c, all GA) the HRV of healthy newborns (as measured by RMSSD) reacts to episodes of 
low BP by increasing its median value from 4.21 (IQR: 3.9 to 4.6) under normal BP to 4.96 (IQR: 4.2 to 5.5) under 
Hypotensive events. At the same time, for unhealthy newborns no such increase is observed, with the median RMSSD value 
of 3.89 (IQR: 3.6 to 4.2) under normal BP and 3.75 (IQR: 3.5 to 4.1) under Hypotensive events.  
Figure 6 shows a comparison between healthy and unhealthy neonates for several relevant HRV features. The obtained 
results indicate that preterms with abnormal outcome have significantly lower values of HRV (p-value<0.001) even for All 
epochs dataset. This separation increases for Hypotensive events as indicated in Table 3 by the increased AUCs.  
 
Fig. 6. Values of HRV features extracted from All epochs for healthy and unhealthy preterm neonates. Boxplot analyses show the median, 
25th and 75th percentiles, and the outliers. „**‟ represent statistically significant differences between groups with p-value<0.001 using 
Mann-Whitney U test. The predictive power of the features quantified by AUC is presented in Table 3 (All epochs, Set 3). 
 
Figure 7 (along with the animation in the supplementary material) shows the 3D projection of the first 3 principal 
















subset. This allows for the visualisation of the discriminative power of a linear transformation (PCA) of the 13 HRV 
characteristics. It can be seen that the combination of multiple features improves the separation in both cases, with very little 
overlap observable for Hypotensive events. 
 
 
Fig. 7. Principal component analysis (PCA) of the dataset comprised of all epochs (a) and epochs during hypotensive episodes (MAP ≤ 
GA+2) (b). In this study PCA is used as a tool for exploratory feature analysis which is aimed at checking the discriminative power of the 
HRV feature set with respect to the short-term outcome of the preterm neonate. 
The aim of any decision support system should be to provide high sensitivity, correctly detecting as many (ideally all) of 
the „unhealthy‟ preterm babies in the NICU. So there is a trade-off here – the choice of a tighter threshold (e.g. MAP ≤ GA) 
will provide a better performance. This performance, however, will come at the cost that some unhealthy babies, who do not 
exhibit any such deep dips in BP across their recording, will be excluded totally from the analysis. This would lead to the risk 
that a substantial number of unhealthy neonates (in our case 4) would not be processed and correctly detected by the 
proposed decision support system. 
The combination of features with boosted decision trees was investigated for Set 3 (MAP ≤ GA+4) since for this threshold 
the separation between healthy and unhealthy newborns is more challenging while all the data can be used. The results of the 
performance of classifier-based systems are presented in Table 4. The prediction systems were designed to run on All epochs 
and Hypotensive events and were scored with respect to their epoch or subject level accuracies. 
 
Table 4. AUC for short-term outcome prediction using various combination of HRV and BP features (MAP≤GA+4). 
 
Predictions on 
Hypotensive event   
Predictions on  
All epochs 





Epoch AUC 0.91 0.90 0.83 0.88 
Subject AUC 0.97 0.96 0.94 0.95 
 
The HRV-based system which is designed to operate on All epochs results in an AUC of 0.83 and 0.94, for the epoch and 
subject level metrics. It can be seen from Table 4 that the subject-level performance is higher than the epoch-level. The 
system improves from an AUC of 0.83 to an AUC of 0.91 when observing only Hypotensive events. An additional 
experiment was conducted where MAP information was provided to the classifiers in the form of two additional features: 
MAP–GA and MAP/GA. This additional information has improved results on All epochs. More specifically, for the model 
trained on the HRV & MAP features, the AUC increased from 0.83 to 0.88. No consistent benefit was observed for 
Hypotensive events where the dataset has been already pre-selected based on the MAP thresholds and thus MAP features do 
not bring any new information. The overall best results both for the epoch and subject-level metrics are obtained with the 
HRV-based system on Hypotensive events with an AUC of 0.91 and 0.97, respectively. 
The importance of the various HRV features was derived from the model trained to use HRV system for Hypotensive 
events. The importance is averaged across 23 models from the patient independent LOO procedure. Figure 8 shows that 
RMSSD, MeanRR, LF/HF, ApEn and LF are the top five most important HRV features. Figure 9 illustrates the top ten two-
feature interactions which have the greatest contribution to the preterm outcome prediction. It can be seen that the RMSSD 
feature is involved in many of the important interactions. This result is consistent with the single feature statistics, where 

















Fig. 8. Mean of the feature importance (gain) reported by the boosted decision tree classifier trained on the HRV features extracted during 
episodes of low BP (MAP ≤ GA+4). 
 
Fig. 9. Representation of the importance (gain) of the top ten two-feature interactions for the short-term outcome prediction. The system is 
trained on all HRV features extracted during the episodes of low BP (MAP ≤ GA+4). 
 
Figure 10 illustrates the most frequently selected sets of hyperparameter during the internal CV for each of the iterations of 
the LOO routine, for the HRV-based system for Hypotensive events. The radius of each sphere indicates the frequency with 
which a particular set of hyperparameters is selected.  
 
Fig. 10. The density of selected tensors of three main hyperparameters obtained during the LOO routine for the HRV-based systems for 
Hypotensive events (MAP≤GA+4). The most frequently selected parameters are Subsample=0.9, Colsample=0.3 and Depth=4. The 
projections of the parameters are represented with dash lines. 
 
The designed systems allow for the continuous observation of the probabilities of morbidity. Figure 11 depicts the 
















Figure 12 presents the probabilistic output for the same unhealthy subject as in Figure 11 across longer recording time, 
where behavior of probability during the Hypotensive events is highlighted. The thresholded trace of MAP illustrates the 
definition of hypotensive events.  
 
Fig. 11. An example of the system output as a continuous probabilistic trace obtained during 10 hours for one healthy (GA=28 weeks, blue 
solid line) and one unhealthy (GA=23 weeks, red dashed line) patients. The system is trained and evaluated on the All epochs dataset. 
 
 
Fig. 12. Comparison of the probabilistic traces for an unhealthy neonate (GA=23 weeks) obtained from the two models trained on HRV 
features extracted from either the All epochs (b) or Hypotensive events (MAP ≤ GA+4) (c) datasets. The model trained on the All epochs 
(b) is represented by instantaneous (red solid thin line) and cumulative (green dashed bold line) probabilistic values. The Hypotensive 
events model (c) is represented by the instantaneous probabilistic values (solid blue thin line) and the cumulative average of prediction 
(solid orange bold line). An average of the morbidity prediction for each model is 0.85 and 0.95 respectively. 
4. DISCUSSION  
4.1. Statistical analysis of HRV features 
This is the first study which investigates an association between HRV and neonatal health outcome for preterms in the 
context of hypotensive episodes. The results from Table 3 indicate that several HRV features are relevant for the chosen task 
and have predictive power with respect to the outcome. These features are RMSSD, ApEn, HF, SDNN, TINN. Moreover, 
HRV features are shown to be sensitive to BP and the features extracted during the episodes of low MAP show better 
separation between good and poor outcomes. Interestingly, the tighter the overall threshold on the definition of the 
hypotension, the larger the improvement in AUC that is observed when comparing All epochs with Hypotensive events. It is 
















by the corresponding GA-based thresholds. For each Set, Hypotensive events come from the same subjects and represent a 
subset of All epochs. Thus, the obtained improvement is purely attributable to the effect that BP has on HRV rather than an 
effect which could have been caused by including extra subjects in the category of All epochs. 
From Figure 5 (a) the RMSDD feature as a measure of the energy of the successive differences between neighbouring RR 
intervals is generally higher for the healthy cohort than unhealthy cohort with a substantial overlap between the two 
distributions. This indicates that the HRV of healthy preterms react to the drop in BP. In [39] the increased level of 
interaction between EEG and BP in preterms was shown to be associated with lower risks of illness severity. Similarly here 
as shown in Figure 5, a strong interaction between HRV and BP is associated with a good outcome, whereas the lack of 
interaction is associated with a poor outcome.  
The most important HRV feature, RMSSD, estimates the short-term component of HRV and represents the 
parasympathetic activity of the heart. In [14] RMSSD was shown to improve 2-year outcome prediction for preterm neonates, 
with lower RMSSD values corresponding to minor neurologic dysfunction and cerebral palsy. Other studies have reported 
that the RMSSD feature is a good early predictor of a septic shock for adults [40] and sudden unexplained death in epilepsy 
[41]. Decreased HRV was previously associated with hypoxic brain injury for newborns [42] and with the failure of the first 
extubation for the preterm infants [18]. This study has also shown that RMSSD values are lower for unhealthy preterm 
neonates. 
Other HRV characteristics which are shown to be relevant to the short-term outcome of the preterm neonate (Table 3) were 
previously reported to be indicative of the neonatal health status. For instance, the ApEn measure was proposed by Pincus 
[26] who previously reported reduced ApEn in distressed foetuses [43] and sick newborns [44]. This can be interpreted as an 
increased regularity of cardiac rhythm. Further application of entropy estimators to neonatal HRV revealed an association 
with neonatal sepsis [45]. In this study, lower ApEn values were obtained for unhealthy preterms. Another examples is the 
TINN characteristic which was previously shown [11] to be significantly associated with severity of the hypoxic ischemic 
encephalopathy for full-term neonates, with lower TINN values corresponding to sick neonates. Similarly, lower TINN 
values in this study are shown to be associated with an increased risk of morbidity of the preterm. 
Neonatal HRV evaluated by spectral analysis is usually characterised by the dominant activity in the LF band. LF is 
mediated predominantly by the sympathetic component of the autonomic nervous system. LF of HRV is also considered to 
represent Mayer waves of BP changes [46]. Mayer waves are cyclic changes in arterial BP at a frequency of about 0.1 Hz 
resulting from oscillation of sympathetic vasomotor tone [47]. Calculation of the LF/HF ratio is a method to establish the 
ratio between the components of the autonomic nervous system – sympathetic/parasympathetic balance [25]. Reduced LF 
and HF features were reported for neonates with hypoxic ischemic encephalopathy, implying the reduction of autonomic 
function [11]. Similar findings were observed in the current study with a decreased power in the LF and HF bands (Figure 6). 
In general, both human and animal studies have supported the finding that reduced spectral power in the low-frequency 
component is indicative of an impaired function of the autonomic nervous system [48,49]. 
Preterm neonates are at high risk of developing sepsis, which is known to be an important risk factor for a prolonged stay 
at the hospital and even death. The heart rate observation monitor (HeRO) which allows for the detection of sepsis in preterm 
infants is based on three HRV characteristics (SDNN, sample asymmetry and sample entropy) combined using logistic 
regression. This algorithm generates a clinical score that quantifies the risk of sepsis in the next 24 hours. In comparison, the 
system developed in this study utilises a more powerful tree-based model to generate a final decision, which is based on 5 
major neonatal complications (including sepsis). At the same time, a feature set of 13 HRV characteristics was used in this 
study which interestingly only shares one common feature with the HeRO monitor – SDNN. 
From Table 1 it can be seen that 3 out of a total of 11 infants with poor outcome were contributed solely by sepsis, 3 poor 
outcomes resulted from complications other than sepsis (NEC and BPD); 4 poor outcomes were contributed by the 
combination of sepsis and other complications; for 1 remaining neonate with sepsis, the information about other 
complications was not available. None of the preterms in the dataset exhibited ROP (stage 2 or greater). The system can 
predict the correct outcome for 2 out of 3 infants without sepsis and for 8 out of 8 infants with sepsis. For this reason, the 
system applicability goes beyond sepsis-affected babies. 
4.2. Machine learning  
 The statistical predictive power measured by the AUC represents statistical descriptive linear inference of a single signal 
characteristic. This measure of separation is computed from all the data and small intra-subject data variability may impact 
the conclusions regarding whether the observed phenomenon generalizes across various subjects. To assess the out-of-sample 
predictive power of a feature or a combination of features then a subject independent performance assessment must be used. 
With machine learning methods, the LOO performance provides estimates of 1) whether individual features bear predictive 
power that generalizes across patients, 2) the predictive power of non-linear correlation between the feature and the label, 3) 
the above for a combination of features. Figure 7 indicates that a combination of features can indeed increase the separation 
















4.2.1. Combination of features with boosted decision trees 
From Table 4, it can be seen that the performance achieved with machine learning has improved when compared with the 
AUCs of single features (Table 3, Set 3). It is important to stress that the performance is assessed using the out-of-sample 
patient predictions. Observing the results it can be concluded that MAP plays an important role in assessing the wellbeing of 
a preterm newborn. When MAP is used to drive the definition of hypotensive events, similar to descriptive statistics the 
performance using machine learning is better, when tested on Hypotensive events as compared to All epochs. Interestingly, 
when MAP is not used to identify hypotensive events (All epochs), the inclusion of MAP-based features similarly improved 
the performance (HRV vs HRV & MAP).  
Comparing the epoch-based and subject-based scores, we can see that the accumulation of probabilistic information across 
the whole recording increases the discriminatory capacity of the classifier, in all considered cases. The performance reported 
at the subject level assumes the availability of the whole recording before decision making. This means that the system 
achieves this performance for prognostication purposes rather than for on-the-fly monitoring and decision making.  
Overall, the use of machine learning allowed us to obtain an AUC of 0.97 for Set 3, which is similar to the result obtained 
with descriptive statistics for a single best feature for Set 1 in Table 3. However, it is important to note that Set 3 includes 8 
more babies, 4 with poor outcome, who could benefit from the continuous physiological data analysis. 
4.2.2. Feature importance & interaction 
The ranking of HRV features for the best system based on information gain shown in Figure 8, is consistent with statistical 
descriptive analysis (Table 3). The most important feature appeared to be RMSSD which is followed by MeanRR. 
Additionally, according to the level of feature interaction (Figure 9), MeanRR is the feature which is involved in the majority 
(7 out of 10) of the top ten two-way interactions. In other words, when considered in a combination with other HRV 
characteristics, MeanRR becomes even more important. This indicates that the absolute heart rate information is 
complementary to many HRV features for the chosen task and HRV should be considered in the context of mean HR. This 
particular result emphasises the power of multi-feature classification.  
4.2.3. Stability of the models 
It can be seen from Figure 10 that while an exhaustive search was performed on the wide range of hyperparameters, the 
choice of the best hyperparameter vector is stable as represented by the densely located sets of best hyperparameters. 
According to the CV performance metric, the best set of hyperparameters for the classifier trained on HRV features from 
Hypotensive events dataset is located at (0.9, 0.3, 4), where x, y, and z are the fraction of the data, features, and depth of the 
tree, respectively. The tree depth of 4 corresponds to a tree, which is capable of creating complex decision boundaries and 
benefiting from the interaction between features. Every tree is built on a randomly selected set of 90% of data and 30% of all 
features. The fact that 30% of features are selected supports the conclusions from the analysis of feature importance and the 
statistical analysis which indicate the presence of many irrelevant features. If we were to generate a single model on all 
available training data to be used in clinical practice, then these hyperparameters should be used to train the final classifier.  
4.2.4. Decision support tools 
From Table 4, various decision support tools can be potentially designed depending on the information available and the 
purpose. Non-invasive techniques for BP measurement are known to be unreliable in small and sick infants. An excessive 
intervention in sick preterm infants is undesirable and a gold standard invasive BP recordings at times may be difficult to 
obtain [51]. On the other hand, non-invasive ECG is routinely recorded in preterms. In this context, depending on the 
physiological data available we have provided 3 possible decision support tools for the clinical prediction of short-term 
outcome: 1) a tool based only on HRV, that assumes that MAP is unavailable and which targets instantaneous diagnosis (All 
epochs, HRV, Epoch AUC) which will provide an AUC of 0.83; 2) a tool which uses HRV and MAP and which also targets 
instantaneous diagnosis running on All epochs, not only on those that meet the threshold MAP ≤ GA+4,  will improve the 
performance to an AUC of 0.88 (All epochs, HRV & MAP, Epoch AUC); 3) if MAP is available and episodes of 
hypotension can be identified, then a decision support tool with the same purpose can achieve an AUC of 0.91 (Hypotensive 
events, HRV, Epoch AUC). If the purpose is switched to prognostication, then an AUC of 0.94 can be obtained without MAP 
and 0.97 with MAP focusing on hypotensive events.  
The GA-based rule of the definition of hypotension is widely used in clinical practice for the treatment of low BP in the 
preterm to decide whether the current low BP is of any risk to the wellbeing of the neonate. In this study, the HRV-based 
systems, All epoch, and Hypotensive events were scored with respect to their epoch and subject level accuracies. Each 
system continuously outputs a probability of morbidity for every five-minute window in real-time as shown in Figure 12. 
Such systems can be used in clinical practice as a decision support tool for the monitoring of preterm neonates, who may 
have low BP. The MAP recording along with the probability traces which are shown in Figure 12, of the two systems, All 
epochs and Hypotensive events, give an additional insight into the interrelation between HRV, BP and neonatal health 
outcome in the context of episodes of low MAP. It can be seen that whereas the system trained on All epochs (Figure 12 (b)) 
















probabilities only on the segments where MAP falls below the predefined threshold. The system designed to operate on 
Hypotensive events outperforms the one designed on All epochs as shown in Table 4. Similarly, in Figure 12, the 
continuous and cumulative average probability of morbidity for a given unhealthy neonate is higher using Hypotensive 
events, 0.95, as compared to 0.85 for All epochs.  
It can be seen from Figure 12 that the cumulative average of probability stabilises quickly and thus can approximate the 
final average probability which is used in the subject-level assessment of accuracy. This implies that with increasing 
monitoring time, tools designed for diagnosis can approach the performance of those designed for prognostication. This is 
represented in Figure 12 (b) as a red solid thin line for instantaneous predictions and green dashed bold line for cumulative 
average probabilistic values, for the HRV only decision support system. A solid blue thin line for instantaneous predictions 
and solid orange bold line for cumulative average probabilistic values in Figure 12 (c) are indicative of the same effect on the 
HRV system for hypotensive events.  
4.3. Limitations 
While the thresholds used to identify low BP are arbitrary, the first definition was based on the MAP≤ GA rule, which is 
one of the most commonly utilized definitions worldwide. The other two definitions /thresholds used were arbitrary and are 
not supported by any clinical use. The natural rise in BP over the first day is approximately 5 mmHg. These two definitions 
of +2 and +4 would remain less than the normal rise noted in healthy preterm infants.  
Other limitations include the potential confounding effect of iatrogenic interventions, such as medications, intubation or 
mechanical ventilation on BP, HRV and the outcome variable (CCS). The availability of additional clinical information 
which accounts for inadequate oxygen delivery to the tissue (e.g. anemia) can potentially help to better define the criteria for 
hypotension definition. These data, however, was not consistently available for the purpose of this retrospective study. 
The results obtained in this study demonstrate the sensitivity of HRV to changes in BP. If a lower GA-based threshold is 
selected, then any event now highlighted as “hypotensive” is, therefore, more severe (lower BP) which results here in an 
improvement in discriminatory power of the features and an increase in the AUC. However, this comes at the cost of a 
reduced number of subjects (fewer babies will have hypotensive events, with this lower threshold) and thus a reduced 
confidence in the observed changes for this lower threshold. It is also possible to show that with a low GA-based threshold 4 
infants with a poor outcome would not be identified and not subjected to AI-assisted monitoring.  
The population of preterm neonates is extremely vulnerable, and it is usually difficult to get the permission for any kind of 
intervention from neonatologists. This, therefore, may introduce a bias in the clinical data, as most of the time only sick 
babies are monitored. In order to better represent the general neonatal population, a larger cohort of preterm infants should be 
used to test the generalisability of the developed system. In this work only preterm infants that had continuous simultaneous 
ECG and MAP recordings that were of good signal quality were studied. 
5. CONCLUSION 
HRV features extracted during episodes of low BP in preterm infants were shown to correlate with short-term health 
outcomes as represented by a clinical course score, with a single best feature (RMSSD) reaching an AUC of 0.87. Combining 
multimodal data of HRV and BP with a machine learning algorithm, a decision support tool for clinical prediction of short-
term outcome in preterms with low BP was constructed. ECG with or without BP records are usually available soon after 
birth and this work presents a promising step towards the use of physiological data in building an objective decision support 
tool for the clinical prediction of short-term outcome in preterms. Future research will concentrate on the incorporation of 
other modalities, such as clinical data, and testing on larger cohorts, for the prediction of both long-term and short-term 
outcome in preterms. In addition, the algorithmic calculation of newborn HRV features used in currently available sepsis 
monitors such as the HeRO monitor should be investigated to assess the level of complementarity of this work. 
ACKNOWLEDGMENT 
This research was supported by a Science Foundation Ireland Research Centers Award (SFI 12/RC/2272). 
CONFLICTS OF INTEREST 
The author declares no conflict of interest. 
APPENDIX 
Given a set of N training examples of the form {                 } such that     
  is a d-dimensional feature vector 
of the i-th example and    is its label, the goal is to create a model,  , to predict values in the form,  ̂  ∑       . At each 
stage of gradient boosting,      , a model,   , is constructed. A new improved model is then constructed,        , that 
adds an estimator, h, as                    , by fitting h to the residuals,           . At each iteration, the algorithm 
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Here   is a differentiable convex loss function that measures the difference between the prediction  ̂  and the target   . Each 
   corresponds to an independent tree structure with a vector of leaf weights  ;   and   are regularization parameters. The 
second term,  , penalizes the complexity of the regression tree functions in terms of the number of leaves in the tree  . The 
regularization term   also helps to smooth the learnt weights to avoid overfitting. 
The final objective function optimized using a second-order Taylor approximation is defined as follows: 
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     are the first and the second order derivatives of the loss 
function at iteration t. This results in the following optimal weight  
  on the jth leaf: 
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where    defines a set of indices of data points that are assigned to the j-th leaf. Learning the structure of the tree    implies 
deciding on how to split the data using features. After each split, the leaf is converted to an internal node. The gain measures 
the improvement brought by each split and is defined as: 
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The first and second terms (Eq. A.5) represent scores for the left and right leaves added; the third term is a score of the 
original leaf prior to the split. The tree is built to the predefined maximum depth. The nodes with negative gain are then 
pruned in a bottom-up order. If the gain is smaller than the regularization parameter  , the split is not produced. Gain is also 
used as a parameter which quantifies the feature importance, by averaging the gain of each feature for all splits and all trees. 
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